ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Seffalair Spiromax 232/14 mcg, Multidosenpulverinhalator - 60
67891003 Teva Pharma AG
Seffalair Spiromax 232/14 mcg, Multidosenpulverinhalator12.04.2021
  12.04.2021
Salmeterol and Fluticasone (R03AK06) 
WHO-DDD11.04.2026
03.04.30.60
03.04.30. 
B  
Yes 
IP 
55.49No
    
10 %80.20
  
7680678910035Synthetika
  
Composition
fluticasoni propionas 202 µg, salmeterolum 12.75 µg ut salmeteroli xinafoas, lactosum monohydricum ad pulverem pro dosi, doses pro vase 60.
Packungsbestandteile
Multidosenpulverinhalator 
  
 
Active AgentDose
Fluticasoni Propionas202 µg
Salmeterol12.75 µg
BAG: Active AgentDose
Fluticasoni-17 Propionas202 mcg
Salmeterol12.75 mcg
 
Inactive agents
Lactose Monohydrate
 
Source
Data was imported : 12.05.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home